talvey
janssen-cilag international n.v. - talquetamab - mnohočetný myelom - antineoplastická činidla - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
rosuvastatin/ezetimib sandoz 10mg/10mg potahovaná tableta
sandoz s.r.o., praha array - 16812 vÁpenatÁ sŮl rosuvastatinu; 16227 ezetimib - potahovaná tableta - 10mg/10mg - rosuvastatin a ezetimib
rosuvastatin/ezetimib sandoz 20mg/10mg potahovaná tableta
sandoz s.r.o., praha array - 16812 vÁpenatÁ sŮl rosuvastatinu; 16227 ezetimib - potahovaná tableta - 20mg/10mg - rosuvastatin a ezetimib
rosuvastatin/ezetimib sandoz 40mg/10mg potahovaná tableta
sandoz s.r.o., praha array - 16812 vÁpenatÁ sŮl rosuvastatinu; 16227 ezetimib - potahovaná tableta - 40mg/10mg - rosuvastatin a ezetimib
rosuvastatin/ezetimib sandoz 5mg/10mg potahovaná tableta
sandoz s.r.o., praha array - 16812 vÁpenatÁ sŮl rosuvastatinu; 16227 ezetimib - potahovaná tableta - 5mg/10mg - rosuvastatin a ezetimib
rosumop 10mg potahovaná tableta
sandoz s.r.o., praha array - 16812 vÁpenatÁ sŮl rosuvastatinu - potahovaná tableta - 10mg - rosuvastatin